Professional Marketing brief: September 2012

Share this article:
Professional Marketing brief: September 2012
Professional Marketing brief: September 2012

Novartis and the University of Pennsylvania have created an alliance to research and develop targeted chimeric antigen receptor (CAR) immunotherapies to treat cancer. Novartis gained exclusive rights to the investigational therapy CART-19, which Penn has begun piloting. The experimental treatments target a protein linked to B-cell malignancies such as chronic lymphocytic leukemia and diffuse large B-cell lymphoma.

Johnson & Johnson has reached an agreement in principle regarding Risperdal allegations, the Wall Street Journal reported. The Journal estimates the agreement could hit $2.2 billion. Johnson & Johnson has been sued over alleged infractions that include encouraging off-label use for the anti-psychotic and improper marketing tactics.

GlaxoSmithKline's $3.6-billion offer for Human Genome Sciences came with an added price. As first reported by the Washington Post, upon the closing of the offer, several HGS board members resigned and were replaced with GSK executives. And following the appointment of the GSK designees, “the HGS Board removed all of the executive officers of HGS,” notes the tender offer statement GSK filed with the SEC.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Upward Move: Jose Rivera

Upward Move: Jose Rivera

Jose Rivera. EVP, account director, Concentric